Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016

Details for Mechanism ID: 16763
Country/Region: Tanzania
Year: 2015
Main Partner: Henry M. Jackson Foundation for the Advancement of Military Medicine
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USDOD
Total Funding: $49,679,079 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $7,237,477
Care: TB/HIV (HVTB) $951,249
Care: Pediatric Care and Support (PDCS) $1,606,889
Laboratory Infrastructure (HLAB) $260,000
Strategic Information (HVSI) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $8,215,670
Prevention: HIV Testing and Counseling (HVCT) $1,655,250
Sexual Prevention: Other Sexual Prevention (HVOP) $785,711
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $5,766,428
Treatment: Adult Treatment (HTXS) $21,593,516
Treatment: Pediatric Treatment (PDTX) $1,606,889
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 145,217
CARE_CURR_TA Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 7
CARE_NEW_DSD Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 33,224
FPINT_SITE_DSD Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2016 281
FPINT_SITE_DSD Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2016 281
GEND_GBV_DSD By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2016 4,565
GEND_GBV_DSD By type of service: Sexual Violence (Post-Rape Care) 2016 4,188
GEND_GBV_DSD Number of people receiving post-GBV care 2016 20,883
GEND_NORM_DSD Number of people completing an intervention pertaining to gender norms, that meets minimum criteria 2016 62,503
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 690,340
HTC_TST_TA Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 2,301
KP_PREV_DSD By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 5,124
KP_PREV_DSD By key population type: Men who have sex with men/Transgender (MSM/TG) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 934
KP_PREV_DSD Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2016 6,058
LAB_ACC_DSD Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2016 3
LAB_CAP_DSD By clinical laboratories 2016 58
LAB_CAP_DSD By Point-of-care testing sites 2016 243
LAB_CAP_DSD Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 301
PMTCT_ARV_DSD Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 11,654
PMTCT_ARV_DSD Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 10,289
PMTCT_ARV_DSD Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 4,478
PMTCT_ARV_DSD Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 5,811
PMTCT_ARV_DSD Sum of New and Current disaggregates 2016 10,289
PMTCT_ARV_TA Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 25
PMTCT_ARV_TA Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 24
PMTCT_ARV_TA Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 9
PMTCT_ARV_TA Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 15
PMTCT_ARV_TA Sum of New and Current disaggregates 2016 24
PMTCT_EID_DSD By infants who received a virologic test within 2 months of birth 2016 5,565
PMTCT_EID_DSD By infants who received their first virologic HIV test between 2 and 12 months of age 2016 2,457
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 8,022
PMTCT_EID_DSD Sum of Infant Age disaggregates 2016 8,022
PMTCT_STAT_DSD By: Known positives at entry 2016 3,542
PMTCT_STAT_DSD By: Number of new positives identified 2016 8,112
PMTCT_STAT_DSD Number of new ANC and L&D clients 2016 141,060
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 132,932
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2016 11,654
PMTCT_STAT_TA By: Known positives at entry 2016 6
PMTCT_STAT_TA By: Number of new positives identified 2016 19
PMTCT_STAT_TA Number of new ANC and L&D clients 2016 1,737
PMTCT_STAT_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 1,704
PMTCT_STAT_TA Sum of Positives Status disaggregates 2016 25
PP_PREV_DSD Age/sex: 15-19 Female 2016 13,426
PP_PREV_DSD Age/sex: 20-24 Female 2016 8,382
PP_PREV_DSD Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 21,808
PP_PREV_DSD Sum of Age/Sex disaggregates 2016 21,808
TB_SCREEN_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 145,217
TB_SCREEN_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 133,789
TB_SCREEN_TA Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 7
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2016 136,032
TX_CURR_TA Number of adults and children receiving antiretroviral therapy (ART) 2016 25
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 31,861
TX_NEW_DSD Pregnancy status 2016 4,034
VMMC_CIRC_DSD By Age: 10-14 2016 50,378
VMMC_CIRC_DSD By Age: 15-19 2016 21,101
VMMC_CIRC_DSD By Age: 20-24 2016 17,175
VMMC_CIRC_DSD By Age: 50+ 2016 754
VMMC_CIRC_DSD By circumcision technique: Surgical VMMC 2016 118,761
VMMC_CIRC_DSD By follow-up status: Number of surgically circumcised clients who did NOT return for follow-up care within 14 days of circumcision surgery 2016 11,068
VMMC_CIRC_DSD By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2016 107,693
VMMC_CIRC_DSD By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2016 116,385
VMMC_CIRC_DSD By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2016 2,376
VMMC_CIRC_DSD Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 118,761
VMMC_CIRC_DSD Sum of age disaggregates 2016 89,408
Cross Cutting Budget Categories and Known Amounts Total: $1,450,000
Food and Nutrition: Policy, Tools, and Service Delivery $50,000
Gender: Gender Based Violence (GBV) $200,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Key Populations: FSW $400,000
Procurement of condoms, lubricants, and other commodities essential to core HIV services for SWs
Monitoring and evaluation of SW programs
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Collection and use of strategic information on SWs and clients
Training of health workers and community outreach workers
Renovation $600,000
Gender: Gender Equality $200,000
Equity in HIV prevention, care, treatment and support
Implementation
Monitoring and Evaluation